EG330513 Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Histone deacetylase (HDAC) inhibitor impacting histone acetylation. Vorinostat influences Gm5111 indirectly by modulating histone acetylation, revealing the epigenetic regulation of Gm5111 expression and potential involvement in chromatin dynamics. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Phosphoinositide 3-kinase (PI3K) inhibitor influencing the PI3K/Akt pathway. LY294002 indirectly impacts Gm5111 through the PI3K/Akt pathway, hinting at Gm5111′s involvement in cell survival, growth, and metabolic regulation in response to various stimuli. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $112.00 $163.00 $928.00 | 19 | |
MEK inhibitor affecting the MAPK pathway. Trametinib influences Gm5111 indirectly through the MAPK pathway, suggesting Gm5111′s potential roles in cellular processes such as proliferation and differentiation, mediated by extracellular signals. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Nuclear factor kappa B (NF-κB) inhibitor impacting inflammatory signaling. BAY 11-7082 indirectly influences Gm5111 through the NF-κB signaling pathway, indicating a potential role for Gm5111 in inflammatory responses and immune regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Bromodomain and extraterminal domain (BET) protein inhibitor affecting gene expression. JQ1 indirectly influences Gm5111 by modulating the expression of genes associated with cellular processes, suggesting a potential role for Gm5111 in transcriptional regulation and epigenetic control. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor affecting the PI3K/Akt pathway. Wortmannin indirectly influences Gm5111 through the PI3K/Akt pathway, implying Gm5111′s roles in cell survival, growth, and metabolic regulation in response to various stimuli. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 mitogen-activated protein kinase (MAPK) inhibitor impacting the MAPK pathway. SB203580 indirectly influences Gm5111 through the MAPK pathway, suggesting Gm5111′s potential roles in cellular responses to stress, inflammation, and growth signals. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
c-Jun N-terminal kinase (JNK) inhibitor affecting the MAPK pathway. SP600125 indirectly influences Gm5111 through the MAPK pathway, indicating Gm5111′s potential role in regulating cellular responses to stress, inflammation, and growth signals. | ||||||
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $130.00 | 12 | |
p38 MAPK inhibitor impacting the MAPK pathway. BIRB 796 indirectly influences Gm5111 through the MAPK pathway, suggesting Gm5111′s potential involvement in cellular responses to stress, inflammation, and growth signals. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
Akt inhibitor affecting the PI3K/Akt pathway. MK-2206 indirectly influences Gm5111 through the PI3K/Akt pathway, hinting at Gm5111′s potential roles in cell survival, growth, and metabolic regulation in response to various stimuli. | ||||||